NCT03810196 CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT Status RECRUITING Phase NA
NCT03792256 Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) Status COMPLETED Phase PHASE1
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT03756675 Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia Status RECRUITING Phase N/A
NCT03743909 Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute Status UNKNOWN Phase N/A
NCT03739606 Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer Status WITHDRAWN Phase PHASE2
NCT03698656 Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers. Status COMPLETED Phase N/A
NCT03672851 Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia Status TERMINATED Phase PHASE1
NCT03669172 Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT03595800 Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen Status COMPLETED Phase PHASE3
NCT03588936 Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant Status TERMINATED Phase PHASE1
NCT03493906 Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment Status COMPLETED Phase NA
NCT03469921 Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 Status COMPLETED Phase N/A
NCT03434730 Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation Status COMPLETED Phase PHASE2
NCT03412409 RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT Status RECRUITING Phase PHASE2
NCT03408223 Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia Status UNKNOWN Phase NA
NCT03408210 Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia Status UNKNOWN Phase NA
NCT03364257 iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients Status UNKNOWN Phase N/A
NCT03316456 Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction Status COMPLETED Phase N/A